The “Normal” FVIII Level Trap in Females with Haemophilia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, posted on LinkedIn:
”The “Normal” FVIII Level Trap in Females with Haemophilia
For decades, we thought: if factors are normal, the patient is “just a carrier” and shouldn’t bleed. At ASH2025, Dr. Jill Johnsen and the 8CHECK program, with over 500 female,s just shattered that rule with data:
- 52% of genotype-positive females with excessive bleeding had FVIII levels ≥ 40%.
- Normal FVIII levels do NOT exclude excessive bleeding.
What This Means for Clinical Practice:
– FVIII is a poor predictor: High variability makes it an unreliable standalone marker for variant status in females.
– Genotyping is essential: It’s not just for “severe” cases. In this cohort, 62% of tested females had a clinically reportable F8 variant.
– Family History Matters: The yield for finding a variant drops significantly without family history (18.6% vs 67.5%), but positive results still occur.”
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis